Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;333:169 (22 July), doi:10.1136/bmj.333.7560.169
Ray Moynihan
Byron Bay, Australia
| The first 150 words of the full text of this article appear below. |
The Swiss drug giant Roche has been accused of breaching the pharmaceutical industry's code of conduct by providing lavish meals to doctors at several of Australia's leading restaurants.
| |||||||||||
The dinners were part of a Roche sponsored scientific symposium on haematology-oncology treatments, which included the company's top selling pharmaceutical, rituximab (MabThera), which has annual sales of more than SFr4bn (£1.8bn;
2.6bn; $3.2bn).
According to documents obtained by the BMJ, Roche spent more than $A65000 (£27 000;
39 000; $49 000) on one meal for almost 300 people at the Guillaume at Bennelong restaurant, in the Sydney Opera House in July 2005.
With spectacular views over Sydney harbour, the restaurant is considered one of Australia's best, boasting the "degustation menu" with multiple courses and fine wines, worth $A200 a head.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?